However, as mentioned above, the pathogenesis of C9orf72-associated ALS/FTD involves multiple pathways, and these small molecule compounds only play a role in a single pathway, thereby limiting its therapeutic effects. This evidence concerns the gene C9orf72 and frontotemporal dementia.